Please login to the form below

Not currently logged in
Email:
Password:

Cinquil

This page shows the latest Cinquil news and features for those working in and with pharma, biotech and healthcare.

CHMP backs GSK's asthma antibody and Novartis' heart failure drug

CHMP backs GSK's asthma antibody and Novartis' heart failure drug

GSK is racing to market alongside other IL-5 inhibitor developers including Teva, which has filed its Cinquil (reslizumab) candidate, and AstraZeneca which is due to submit benralizumab for approval next

Latest news

  • Teva set for FDA verdict on reslizumab early next year Teva set for FDA verdict on reslizumab early next year

    Ruling for severe asthma therapy Cinquil expected by March 2016.  . The clock has started ticking on Teva's US marketing application for severe asthma therapy Cinquil, with an FDA ruling now ... The US regulator has accepted Teva's Biologics License

  • GSK’s new asthma biologic gains FDA panel backing GSK’s new asthma biologic gains FDA panel backing

    Mepolizumab is also vying with other new drug candidates in late-stage trials for severe asthma, notably AstraZeneca's benralizumab and Teva's Cinquil (reslizumab), both IL-5 inhibitors, as well

  • GSK set to file severe asthma candidate by year-end GSK set to file severe asthma candidate by year-end

    Mepolizumab is also vying with other new drug candidates in late-stage trials for severe asthma, notably AstraZeneca's benralizumab and Teva's Cinquil (reslizumab), both IL-5 inhibitors, as well

  • AZ takes severe asthma antibody into phase III AZ takes severe asthma antibody into phase III

    Benralizumab - which was originally licensed from Japanese company BioWa - is in the same drug class as Teva's Cinquil (reslizumab) and GlaxoSmithKline's mepolizumab, which are both already in phase III

  • Advancing acquisitions

    It acquired Ception via an option enabling Cephalon to judge the performance of Cinquil in phase II studies before taking up the option. ... 272. Ipsen/Inspiration Biopharmaceuticals . haemophilia franchise. Acquisition, various . 259. Ception/Cephalon.

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics